Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Cash from Operations (2024 - 2025)

BioAge Labs (BIOA) has disclosed Cash from Operations for 2 consecutive years, with 28251000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 449.84% to 28251000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 81627000.0 through Dec 2025, down 58.43% year-over-year, with the annual reading at 81627000.0 for FY2025, 58.43% down from the prior year.
  • Cash from Operations hit 28251000.0 in Q4 2025 for BioAge Labs, down from 16044000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 5138000.0 in Q4 2024 to a low of 28251000.0 in Q4 2025.